The Future of Fertility and Non-Surgical Birth Control with Kathy Lee-Sepsick – Health Innovation Matters
Michael chats with Kathy Lee-Sepsick, CEO and Founder of Femasys. Together, they discuss the founding of Femasys and the products it offers, how Kathy has gone about raising capital for a women’s health company despite a challenging lack of sector investment, the importance of gathering thorough safety data for regulatory approvals and commercialization, how Kathy envisions the global commercialization rollout for FemaSeed and FemBloc in the coming months, and much more.
To learn more about Femasys and its products, visit Femasys.com.
About Our Guest
Kathy Lee-Sepsick is the CEO and Founder of Femasys, which was established in February 2004. Kathy brings nearly three decades of leadership in the medical technology industry, including a proven track record in scaling emerging companies and operating divisions. Kathy holds more than 200 global patents for Femasys products and candidates.
Health Innovation Matters 